Healthtech startup Mykare raises $1 million to boost AI capabilities

The startup plans to deploy the fresh funds to enhance its AI capabilities, accelerate product development and expand deeper into existing international markets

Mykare claims its AI-native healthcare OS helps clinics and hospitals automate the entire patient journey, from patient acquisition and appointment booking to feedback and retention

Its AI agents can identify patient intent, answer calls through voice AI, book appointments, manage follow-ups, collect feedback, and automatically update CRM records

The startup said the additional funding was part of the seed round it raised in 2023. Mykare had then bagged $2.2 Mn from OnDeck ODX, Avaana Seed and others.

The startup plans to deploy the fresh funds to enhance its AI capabilities, accelerate product development and expand deeper into existing international markets, cofounder Senu Sam told Inc42.

Founded in 2022 by Sam, Rahmatulla TM, and Joash Philipose, Mykare initially connected patients with its network of hospitals, offering affordable facilities. However, it pivoted to a B2B business model from B2C in October 2025.

Now, it operates an agentic AI and voice AI platform helping small and medium sized hospitals and medical centres increase sales, improve patient experience, and automate operational workflows.

The startup claims its AI-native healthcare operating system (OS) helps clinics and hospitals automate the entire patient journey, from patient acquisition and appointment booking to feedback and retention.

It claims its AI agents can identify patient intent, answer calls through voice AI, book appointments, manage follow-ups, collect feedback, and automatically update CRM records.

“Our AI agents are embedded in 30-35 larger healthcare facilities, while about 45 more clinics have signed up for implementation. We are aiming to touch 100 clinics soon,” Sam said.

Overall, Mykare onboarded 30+ hospitals and clinics providers spans the US, the UK, the Middle East and India. It claims to have a waiting list of more than 20 hospitals and healthcare providers.

“In India, Mykare’s services are active in most metro cities like Delhi NCR, Mumbai, Bengaluru and Hyderabad. Apart from that, in the US, Mykare is tied up with a large oncology clinic chain and a large dental chain in the UK. We are currently also in talks with one of the largest dental chains in Qatar,” the cofounder said.

The fundraise comes as India’s healthtech ecosystem is rapidly moving beyond conventional offerings, with startups using AI not only for patient management but also preventive healthcare, recovery and stress management. This has come on the back of surging consumer demand for integrated wellness platforms spanning diagnostics, coaching, nutrition and skincare.

Investor appetite for the segment has also grown notably in recent months. Just weeks ago, paediatric healthcare brand Hoola Health (erstwhile BabyMD) raised $5 Mn in a round led by Peak XV’s Surge. In May, wearable healthtech startup Gabit bagged ₹36.2 Cr in a funding round from a clutch of angel investors.

At the heart of all this is the homegrown healthtech sector, which is projected to become a $37 Bn opportunity by 2030.